Enzymatic inactivation of endogenous IgG by IdeS enhances therapeutic antibody efficacy
Endogenous plasma IgG sets an immunological threshold that dictates the activity of tumor-directed therapeutic antibodies. Saturation of cellular antibody receptors by endogenous antibody limits antibody-dependent cell-mediated cytotoxicity (ADCC) and antibody dependent cellular phagocytosis (ADCP)....
Main Authors: | Järnum, S, Runström, A, Bockermann, R, Winstedt, L, Crispin, M, Kjellman, C |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
American Association for Cancer Research
2017
|
Lignende værker
-
IgG endopeptidase in highly sensitized patients undergoing transplantation
af: Jordan, S, et al.
Udgivet: (2017) -
Clinical significance of unexpected antibody from IgG1 and IgG3 subtypes
af: LI Zhu, et al.
Udgivet: (2024-11-01) -
Structural and functional characterization of IgG- and non-IgG-based T-cell-engaging bispecific antibodies
af: Nishant Mohan, et al.
Udgivet: (2024-05-01) -
IgG1 versus IgG3: influence of antibody-specificity and allotypic variance on virus neutralization efficacy
af: Somanath Kallolimath, et al.
Udgivet: (2024-10-01) -
MOG-IgG1 antibodies in children
af: Waters, P, et al.
Udgivet: (2018)